medroxyprogesterone acetate 10 MG Oral Tablet [Provera]
- RxCUI
- 1000124
- RxNorm name
- medroxyprogesterone acetate 10 MG Oral Tablet [Provera]
- Display name
- PROVERA (Oral Pill)
- Full name
- medroxyprogesterone acetate 10 MG Oral Tablet [Provera]
- Term type
- SBD
- Status
- Active
- Strength
- 10 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-21 07:26:21
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| medroxyprogesterone acetate | 10 MG / 1 EACH | medroxyprogesterone | medroxyprogesterone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| medroxyprogesterone | 6691 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Provera 10 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | medroxyprogesterone acetate 10 MG Oral Tablet [Provera] | 1 | NAMES |
| RxNorm Synonym | Provera 10 MG Oral Tablet | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | a586be28-96af-4fed-a13f-9b94fd4c7405 | 1 | CODES |
| RxCUI | 1000124 | 1 | CODES |
| MMSL_CODE | BD1847 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0009-0051-01 | 0009-0051 | Provera medroxyprogesterone acetate | Pharmacia & Upjohn Company LLC | NDA011839 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | a586be28-96af-4fed-a13f-9b94fd4c7405 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 0009-0051-01 0009-0051 00009005101 1000124 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a586be28-96af-4fed-a13f-9b94fd4c7405 | Provera 10 MG Oral Tablet [PSN] · medroxyprogesterone acetate 10 MG Oral Tablet [Provera] [SBD] · Provera 10 MG Oral Tablet [SY] | 3 | 26 | PROVERA® (medroxyprogesterone acetate tablets, USP) | 20240830 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| a586be28-96af-4fed-a13f-9b94fd4c7405 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | 20260629 |
| a586be28-96af-4fed-a13f-9b94fd4c7405 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | Pfizer Inc | 20240830 |
| 3f6529dd-3172-442c-922c-3337ad4ca037 | National Council for Prescription Drug Programs | 20120724 | |
| 648174bf-c531-47dd-870d-6f0213794ea0 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03DA | Pregnen (4) derivatives | ATC1-4 | medroxyprogesterone | |
| ATC | L02AB | Progestogens | ATC1-4 | medroxyprogesterone | |
| ATC | G03AC | Progestogens | ATC1-4 | medroxyprogesterone | |
| FDASPL | D045167 | Progesterone Congeners | CHEM | has_chemical_structure | medroxyprogesterone |
| FDASPL | N0000175602 | Progestin | EPC | has_epc | medroxyprogesterone |
| MEDRT | D008525 | Medroxyprogesterone | CHEM | has_ingredient | medroxyprogesterone |
| MEDRT | D017258 | Medroxyprogesterone Acetate | CHEM | has_ingredient | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone acetate |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone acetate |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 10 MG (expressed as medroxyprogesterone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA011839 |
| NAMES | Prescribable Synonym | Provera 10 MG Oral Tablet |
| NAMES | Tallman Synonym | medroxyPROGESTERone acetate 10 MG Oral Tablet [Provera] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |